Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06672718
PHASE1

A Study of SPY002-091 in Healthy Volunteers

Sponsor: Spyre Therapeutics, Inc.

View on ClinicalTrials.gov

Summary

This is a Phase 1, randomized, double-blind, placebo-controlled, single- dose, first in human safety, tolerability, and pharmacokinetic study of SPY002-091 in healthy participants.

Official title: A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of SPY002-091 in Healthy Participants

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

56

Start Date

2024-11-26

Completion Date

2026-06-22

Last Updated

2025-08-17

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

SPY002-091

Experimental

OTHER

Placebo

Placebo

Locations (1)

Spyre Site 1

Cypress, California, United States